[Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses]
- PMID: 1650105
[Comparative effectiveness of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses]
Abstract
To specify differentiated indications for preventive use of normothymic drugs, a prospective study was made of 3 groups of patients with phasic endogenous psychoses, comparable as regards the main ++clinico-anamnestic characteristics. The patients had been administered lithium carbonate (LC, 30 persons), carbamazepine (CRB, 30 patients), and sodium valproate (SV, 28 patients) for no less than one year. It was discovered that all the drugs exhibited marked preventive action to an equal degree. The mean annual magnitude of the total duration of the affective symptomatology reduced by 49.3% in LC administration, by 55.9% in CRB, and by 45.6% in SV administration; the rate of episodes decreased by 53.8, 57.5 and 52.2%, respectively. The anticonvulsants produced a stable preventive effect more rapidly (within the first 2-3 months of the treatment) as compared to LC. CRB had a more pronounced preventive efficacy in atypical affective and schizoaffective psychoses as well as in depressions, particularly in those with predominance of anxiety. As for its activity profile, SV approximated LC and was more effective in psychic endogenomorphous variants of MDP with a typical circadian vital symptom-complex. Unlike LC, the anticonvulsants demonstrated a well-defined capacity to interrupt the continual course of circulatory disorders including the "rapid cyclicity" phenomenon.
Similar articles
-
[Comparative features of the preventive action of carbamazepine and lithium carbonate in affective and schizoaffective psychoses].Zh Nevropatol Psikhiatr Im S S Korsakova. 1989;89(12):64-71. Zh Nevropatol Psikhiatr Im S S Korsakova. 1989. PMID: 2517374 Russian.
-
[Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(9):79-82. Zh Nevropatol Psikhiatr Im S S Korsakova. 1990. PMID: 2176049 Russian.
-
[Use of electroconvulsive therapy for breaking the continual course of drug-resistant affective and schizoaffective psychoses].Zh Nevropatol Psikhiatr Im S S Korsakova. 1990;90(4):121-5. Zh Nevropatol Psikhiatr Im S S Korsakova. 1990. PMID: 2167575 Russian.
-
Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium.J Clin Psychopharmacol. 1992 Feb;12(1 Suppl):23S-35S. doi: 10.1097/00004714-199202001-00005. J Clin Psychopharmacol. 1992. PMID: 1541715 Review.
-
Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.Psychol Med. 1982 Nov;12(4):701-4. doi: 10.1017/s003329170004900x. Psychol Med. 1982. PMID: 6130553 Review. No abstract available.
Cited by
-
Valproate for acute mania.Cochrane Database Syst Rev. 2019 Oct 7;10(10):CD004052. doi: 10.1002/14651858.CD004052.pub2. Cochrane Database Syst Rev. 2019. PMID: 31621892 Free PMC article. Review.
-
Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder.Medicina (Kaunas). 2021 Apr 30;57(5):433. doi: 10.3390/medicina57050433. Medicina (Kaunas). 2021. PMID: 33946323 Free PMC article. Review.
-
Electroconvulsive Therapy (ECT) in Bipolar Disorder Patients with Ultra-Rapid Cycling and Unstable Mixed States.Medicina (Kaunas). 2021 Jun 15;57(6):624. doi: 10.3390/medicina57060624. Medicina (Kaunas). 2021. PMID: 34203943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials